EE200000674A - Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks - Google Patents

Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks

Info

Publication number
EE200000674A
EE200000674A EEP200000674A EEP200000674A EE200000674A EE 200000674 A EE200000674 A EE 200000674A EE P200000674 A EEP200000674 A EE P200000674A EE P200000674 A EEP200000674 A EE P200000674A EE 200000674 A EE200000674 A EE 200000674A
Authority
EE
Estonia
Prior art keywords
preparation
improved process
pharmaceutically valuable
norbenzomorphane
derivatives
Prior art date
Application number
EEP200000674A
Other languages
English (en)
Inventor
Grauert Matthias
Baltes Hanfried
Schnaubelt J�rgen
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200000674A publication Critical patent/EE200000674A/et
Publication of EE04305B1 publication Critical patent/EE04305B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
EEP200000674A 1998-05-20 1999-05-07 Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks EE04305B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19822822A DE19822822A1 (de) 1998-05-20 1998-05-20 Verbessertes Verfahren zur Herstellung von pharmazeutisch wertvollen Norbenzomorphanderivaten
PCT/EP1999/003142 WO1999059976A1 (de) 1998-05-20 1999-05-07 Verbessertes verfahren zur herstellung von pharmazeutisch wertvollen norbenzomorphanderivaten

Publications (2)

Publication Number Publication Date
EE200000674A true EE200000674A (et) 2002-04-15
EE04305B1 EE04305B1 (et) 2004-06-15

Family

ID=7868527

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000674A EE04305B1 (et) 1998-05-20 1999-05-07 Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks

Country Status (38)

Country Link
US (1) US6124459A (et)
EP (1) EP1080076B1 (et)
JP (1) JP4526185B2 (et)
KR (1) KR20010043703A (et)
CN (1) CN1113058C (et)
AR (1) AR016040A1 (et)
AT (1) ATE254605T1 (et)
AU (1) AU753563B2 (et)
BG (1) BG104964A (et)
BR (1) BR9910603A (et)
CA (1) CA2330669C (et)
CO (1) CO5060460A1 (et)
DE (2) DE19822822A1 (et)
DK (1) DK1080076T3 (et)
EA (1) EA003059B1 (et)
EE (1) EE04305B1 (et)
EG (1) EG21526A (et)
ES (1) ES2211093T3 (et)
HK (1) HK1035728A1 (et)
HR (1) HRP20000793A2 (et)
HU (1) HUP0102034A3 (et)
ID (1) ID27014A (et)
IL (1) IL138998A0 (et)
MY (1) MY120806A (et)
NO (1) NO317302B1 (et)
NZ (1) NZ508845A (et)
PE (1) PE20000558A1 (et)
PL (1) PL343935A1 (et)
PT (1) PT1080076E (et)
SI (1) SI1080076T1 (et)
SK (1) SK283996B6 (et)
TR (1) TR200003360T2 (et)
TW (1) TW455582B (et)
UA (1) UA59448C2 (et)
UY (1) UY25515A1 (et)
WO (1) WO1999059976A1 (et)
YU (1) YU71400A (et)
ZA (1) ZA200005740B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405149B1 (en) * 1998-12-21 2008-07-29 Megica Corporation Post passivation method for semiconductor chip or wafer
WO2016044546A1 (en) * 2014-09-17 2016-03-24 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
CN107089948B (zh) * 2017-04-28 2020-07-17 云南大学 吗吩衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34235B1 (en) * 1969-06-04 1975-03-19 Acf Chemiefarma Nv 6,7-benzomorphans and their preparation
US3932422A (en) * 1974-05-20 1976-01-13 Sterling Drug Inc. 8-Methylene-3-azabicyclo[3.3.1]non-6-en-4-ones
US4255579A (en) * 1974-05-20 1981-03-10 Sterling Drug Inc. 11-Substituted hexahydro-2,6-methano-3-benzazocines
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
PT1080076E (pt) 2004-04-30
CN1301256A (zh) 2001-06-27
PE20000558A1 (es) 2000-06-28
UY25515A1 (es) 1999-12-13
AU4139999A (en) 1999-12-06
IL138998A0 (en) 2001-11-25
AR016040A1 (es) 2001-05-30
HK1035728A1 (en) 2001-12-07
HRP20000793A2 (en) 2001-10-31
KR20010043703A (ko) 2001-05-25
TW455582B (en) 2001-09-21
DK1080076T3 (da) 2004-03-22
TR200003360T2 (tr) 2001-06-21
WO1999059976A1 (de) 1999-11-25
EP1080076A1 (de) 2001-03-07
JP2002515491A (ja) 2002-05-28
SK17312000A3 (sk) 2001-06-11
SI1080076T1 (en) 2004-04-30
EA200001212A1 (ru) 2001-04-23
HUP0102034A3 (en) 2002-02-28
UA59448C2 (uk) 2003-09-15
CN1113058C (zh) 2003-07-02
YU71400A (sh) 2003-04-30
CA2330669C (en) 2008-07-15
EP1080076B1 (de) 2003-11-19
NZ508845A (en) 2002-11-26
EA003059B1 (ru) 2002-12-26
DE19822822A1 (de) 1999-11-25
ATE254605T1 (de) 2003-12-15
EG21526A (en) 2001-11-28
US6124459A (en) 2000-09-26
NO20005818D0 (no) 2000-11-17
AU753563B2 (en) 2002-10-24
MY120806A (en) 2005-11-30
SK283996B6 (sk) 2004-07-07
NO317302B1 (no) 2004-10-04
PL343935A1 (en) 2001-09-10
BG104964A (en) 2001-07-31
JP4526185B2 (ja) 2010-08-18
ES2211093T3 (es) 2004-07-01
DE59907804D1 (de) 2003-12-24
ID27014A (id) 2001-02-22
CO5060460A1 (es) 2001-07-30
NO20005818L (no) 2000-11-17
ZA200005740B (en) 2001-10-17
BR9910603A (pt) 2001-01-16
HUP0102034A2 (hu) 2001-12-28
EE04305B1 (et) 2004-06-15
CA2330669A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
NO20006039L (no) Fremgangsmåte for fremstilling av 4-karboksyamino-2- substituert-1,2,3,4- tetrahydroquinolin
NO20013569D0 (no) Fremgangsmåte ved fremstilling av L-fenylephrine-hydroklorid
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20024058D0 (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
AU6123099A (en) Process for the preparation of amine derivatives
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
GB2363605B (en) Process for the preparation of alpha-aminoketone derivatives
EE200000674A (et) Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks
NO20013995D0 (no) Fremgangsmate for fremstilling av L-sorbose
IL138843A0 (en) Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
FI971964A (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
FI951047A0 (fi) Menetelmä indolijohdannaisten valmistamiseksi
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20002558D0 (no) FremgangsmÕte for fremstilling av findisperse eksplosivstoffer
TH34294B (th) กระบวนการสำหรับการเตรียมคลอโรเบบโซซาโซล

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20050507